Security News > 2022 > June > CISA Warned About Critical Vulnerabilities in Illumina's DNA Sequencing Devices

The U.S. Cybersecurity and Infrastructure Security Agency and Food and Drug Administration have issued an advisory about critical security vulnerabilities in Illumina's next-generation sequencing software.

The issues impact software in medical devices used for "Clinical diagnostic use in sequencing a person's DNA or testing for various genetic conditions, or for research use only," according to the FDA. "Successful exploitation of these vulnerabilities may allow an unauthenticated malicious actor to take control of the affected product remotely and take any action at the operating system level," CISA said in an alert.

"An attacker could impact settings, configurations, software, or data on the affected product and interact through the affected product with the connected network."

CVE-2022-1517 - A remote code execution vulnerability at the operating system level that could allow an attacker to tamper with settings and access sensitive data or APIs.

CVE-2022-1518 - A directory traversal vulnerability that could allow an attacker to upload malicious files to arbitrary locations.

CVE-2022-1524 - A lack of TLS encryption for LRM versions 2.4 and lower that could be abused by an attacker to stage a man-in-the-middle attack and access credentials.

News URL

https://thehackernews.com/2022/06/cisa-warned-about-critical.html